Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 597.67% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 690.7% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 12/16/2022 | -16.28% | 杰富瑞 | $30 → $3.6 | 评级下调 | 购买→Hold |
| 10/10/2022 | 597.67% | 杰富瑞 | → $30 | 开始承保 | →购买 |
| 10/10/2022 | 690.7% | 摩根士丹利 | → $34 | 开始承保 | →超重 |
| 10/10/2022 | — | 考恩公司 | 开始承保 | →跑赢大盘 |
What is the target price for Third Harmonic Bio (THRD)?
Third Harmonic Bio(THRD)的目标价格是多少？
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Jefferies on October 10, 2022. The analyst firm set a price target for $30.00 expecting THRD to rise to within 12 months (a possible 597.67% upside). 3 analyst firms have reported ratings in the last year.
杰富瑞于2022年10月10日报道了Third Harmonic Bio(纳斯达克：TRID)的最新目标价。这家分析公司将目标价定为30美元，预计THRD将在12个月内升至(可能上涨597.67)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
分析师对Third Harmonic Bio(THRD)的最新评级是多少？
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Jefferies, and Third Harmonic Bio initiated their buy rating.
第三和谐生物(纳斯达克：TRD)的最新分析师评级由杰富瑞提供，第三和谐生物启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
下一次分析师对Third Harmonic Bio(THRD)的评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Third Harmonic Bio的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Third Harmonic Bio的最后一次评级是在2022年10月10日提交的，所以你应该预计下一次评级将在2023年10月10日左右的某个时候提供。
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
分析师对Third Harmonic Bio(THRD)的评级正确吗？
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $30.00. The current price Third Harmonic Bio (THRD) is trading at is $4.30, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Third Harmonic Bio(THRD)评级是以0.00美元至30.00美元的目标价启动的。目前Third Harmonic Bio(THRD)的交易价格为4.30美元，在分析师的预测范围内。
